Health
BAT’s COVID-19 vaccine candidate gets FDA approval for human study – Reuters
British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug…
By Reuters Staff
Dec 16 (Reuters) – British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug Administration for Phase I human study.
The Worlds No.2 cigarette company had earlier this year said it was working on a COVID-19 vaccine using proteins extracted from tobacco leaves.
The company said the enrolment for the study is expected to begin shortly.
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General22 hours agoRed tape on chopping block in bid to build homes faster
-
Noosa News24 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich